Ping Bie
Overview
Explore the profile of Ping Bie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
3291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al.
Liver Cancer
. 2021 Jan;
9(6):682-720.
PMID: 33442540
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat...
12.
Zhang C, Zhang C, Xing H, Wang Y, Liang L, Diao Y, et al.
Cancer Manag Res
. 2020 Oct;
12:9929-9939.
PMID: 33116850
Background: A normal albumin-to-globulin ratio (NAGR) in serum is greater than 1. Inversed albumin-to-globulin ratio (IAGR < 1) indicates poor synthetic liver function or malnutrition. The aim of this study...
13.
Tan Y, Lin X, Luo Y, Zhang J, Fang L, Zhu Y, et al.
Oncol Lett
. 2020 Sep;
20(5):216.
PMID: 32963622
Aberrantly low expression of NF-κB inhibitor α (IκBα) is observed in hepatocellular carcinoma (HCC), yet the underlying mechanism via which IκBα regulates HCC remains largely unknown. Therefore, to determine the...
14.
Zhou T, Liu L, Dai H, Zhang C, He Y, Zhang L, et al.
J Surg Oncol
. 2020 Aug;
122(7):1418-1425.
PMID: 32794267
Background: Body mass index (BMI) has been widely used as a prognostic indicator. The association between preoperative BMI and postoperative morbidity in patients with hilar cholangiocarcinoma (HCCA) has not been...
15.
Luo Y, Fang L, Yu H, Zhang J, Lin X, Liu X, et al.
J Hepatol
. 2020 Aug;
74(1):96-108.
PMID: 32738450
Background & Aims: p53 mutations occur frequently in human HCC. Activation of the mammalian target of rapamycin (mTOR) pathway is also associated with HCC. However, it is still unknown whether...
16.
Luo Y, Yu H, Liu X, Huang D, Dai H, Fang L, et al.
Cancer Med
. 2020 Apr;
9(12):4083-4094.
PMID: 32293796
Purpose: Hepatocellular carcinoma (HCC) is a common malignant cancer and the third leading cause of death worldwide. The molecular mechanism of HCC remains unclear. Recent studies have demonstrated that the...
17.
Dai H, Liang L, Zhang C, Cheng Z, Peng Y, Zhang Y, et al.
HPB (Oxford)
. 2020 Apr;
22(12):1722-1731.
PMID: 32284280
Background: Iatrogenic biliary injury (IBI) following laparoscopic cholecystectomy (LC) is the most serious iatrogenic complications. Little is known whether LC-IBI would lead to surgeon's severe mental distress (SMD). Methods: A...
18.
Gong Y, Dai H, Shu J, Liu W, Bie P, Zhang L
J Cancer
. 2020 Jan;
11(4):940-948.
PMID: 31949497
Pancreatic cancer is a highly invasive malignant tumor of the digestive system. To explore the mechanism of pancreatic cancer development, development, invasion and metastasis, in this study we focused on...
19.
Luo Y, Zhang J, Fang L, Zhu Y, You Y, Zhang C, et al.
Carcinogenesis
. 2019 Aug;
41(5):689-698.
PMID: 31400758
Hepatocellular carcinoma (HCC) is reported to associate with abnormal expression of SCF E3 ubiquitin ligases. FBXW10, an F-box protein of the E3 ubiquitin ligases, was abnormally regulated in HCC patients....
20.
Dai H, Shen K, Yang Y, Su X, Luo Y, Jiang Y, et al.
Cell Death Dis
. 2019 Aug;
10(8):595.
PMID: 31395860
Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with very poor prognosis. Therefore, it is important to fully understand the molecular mechanism underlying its occurrence and development. Pumilio RNA-binding family...